Can the influenza vaccine be given before or after a tuberculin skin test (Mantoux) without affecting the test results?

Influenza Vaccine and TB Skin Test Timing

The influenza vaccine can be administered simultaneously with a tuberculin skin test (TST) without affecting the accuracy of the TST results, and there is no need to separate these procedures.

Key Recommendation

The primary concern with live-attenuated viral vaccines and TST is that certain live vaccines (measles, mumps, rubella, varicella, yellow fever) can suppress tuberculin reactivity if given within 48 hours before TST placement. However, influenza vaccine is an inactivated vaccine, not a live vaccine 1, and therefore does not cause immunosuppression that would interfere with TST interpretation.

Evidence-Based Guidance

Live vs. Inactivated Vaccines

The critical distinction is between vaccine types:

• Live-attenuated vaccines can suppress PPD response in tuberculin-positive patients, but this suppression does not appear within the first 48 hours after vaccination 2
• Inactivated influenza vaccine does not trigger the immunosuppressive mechanisms that affect TST reactivity 3

Timing Recommendations

According to CDC/ACIP guidelines 4:

• Tuberculin testing should be done either on the same day as live virus vaccination OR 4-6 weeks later to avoid the window of potential immunosuppression
• This timing concern does not apply to inactivated vaccines like influenza vaccine

Practical Application

You can proceed with either approach:

1. Administer both on the same day - Place TST and give influenza vaccine during the same visit, then read TST at 48-72 hours 5

2. Give in any sequence without waiting - Influenza vaccine before or after TST placement requires no specific interval

3. No need to delay TST reading - The standard 48-72 hour reading window remains valid regardless of influenza vaccination timing 5

Important Caveats

What NOT to Confuse

• BCG vaccination (a live mycobacterial vaccine) can cause false-positive TST results that may persist for decades 6, but this is unrelated to influenza vaccine timing
• The booster phenomenon with repeat TST is a separate issue from vaccine interference 5
• Research showing cutaneous reactions to influenza vaccine 7 represents local injection site reactions, not systemic immunosuppression affecting TST

TST Interpretation Remains Standard

• Use the ≥5 mm induration cutoff for TB contacts regardless of influenza vaccination 5
• The 8-10 week window period after TB exposure for repeat testing is unchanged by influenza vaccination 5
• Document any previous positive TST before administering new tests 5

Clinical Bottom Line

There is no immunologic or clinical reason to separate influenza vaccination from tuberculin skin testing. The convenience of administering both during a single healthcare encounter outweighs any theoretical concerns, as inactivated influenza vaccine does not suppress cell-mediated immunity required for TST reactivity. This allows for efficient preventive care delivery, particularly important during influenza season when both interventions may be indicated.